Logo image of REVX.CA

REV EXPLORATION CORP (REVX.CA) Stock Fundamental Analysis

TSX-V:REVX - TSX Venture Exchange - CA7613251098 - Common Stock - Currency: CAD

0.29  +0.01 (+3.57%)

Fundamental Rating

0

Overall REVX gets a fundamental rating of 0 out of 10. We evaluated REVX against 818 industry peers in the Metals & Mining industry. Both the profitability and financial health of REVX have multiple concerns. REVX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

REVX had negative earnings in the past year.
In the past year REVX has reported a negative cash flow from operations.
REVX had negative earnings in each of the past 5 years.
REVX had a negative operating cash flow in each of the past 5 years.
REVX.CA Yearly Net Income VS EBIT VS OCF VS FCFREVX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -500K -1M -1.5M -2M

1.2 Ratios

REVX has a Return On Assets of -99.83%. This is in the lower half of the industry: REVX underperforms 74.33% of its industry peers.
Industry RankSector Rank
ROA -99.83%
ROE N/A
ROIC N/A
ROA(3y)-197.56%
ROA(5y)-225.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
REVX.CA Yearly ROA, ROE, ROICREVX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K

1.3 Margins

REVX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
REVX.CA Yearly Profit, Operating, Gross MarginsREVX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023

1

2. Health

2.1 Basic Checks

REVX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for REVX has been reduced compared to 5 years ago.
There is no outstanding debt for REVX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
REVX.CA Yearly Shares OutstandingREVX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
REVX.CA Yearly Total Debt VS Total AssetsREVX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M

2.2 Solvency

Based on the Altman-Z score of -192.21, we must say that REVX is in the distress zone and has some risk of bankruptcy.
REVX has a Altman-Z score of -192.21. This is amonst the worse of the industry: REVX underperforms 85.70% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -192.21
ROIC/WACCN/A
WACCN/A
REVX.CA Yearly LT Debt VS Equity VS FCFREVX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1M -2M

2.3 Liquidity

REVX has a Current Ratio of 0.28. This is a bad value and indicates that REVX is not financially healthy enough and could expect problems in meeting its short term obligations.
REVX has a worse Current ratio (0.28) than 73.59% of its industry peers.
A Quick Ratio of 0.28 indicates that REVX may have some problems paying its short term obligations.
REVX has a worse Quick ratio (0.28) than 72.49% of its industry peers.
Industry RankSector Rank
Current Ratio 0.28
Quick Ratio 0.28
REVX.CA Yearly Current Assets VS Current LiabilitesREVX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M

0

3. Growth

3.1 Past

REVX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -122.87%.
EPS 1Y (TTM)-122.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.78%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for REVX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
REVX.CA Price Earnings VS Forward Price EarningsREVX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
REVX.CA Per share dataREVX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0 0 0 0

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

REVX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

REV EXPLORATION CORP

TSX-V:REVX (5/9/2025, 7:00:00 PM)

0.29

+0.01 (+3.57%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.2%
Inst Owner ChangeN/A
Ins Owners9.24%
Ins Owner ChangeN/A
Market Cap7.61M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -99.83%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-197.56%
ROA(5y)-225.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.28
Quick Ratio 0.28
Altman-Z -192.21
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-122.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.78%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y90.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y90.49%
OCF growth 3YN/A
OCF growth 5YN/A